Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegaspargase Management in ENKTL
NCT05426824Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Open-label trial of pegaspargase in Extranodal NK/T-cell lymphoma (ENKTL), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Plasma activity curve of pegaspargase. Status: unknown.
02
Drugs
pegaspargase
03
Conditions
Extranodal NK/T-cell lymphoma (ENKTL)
Beyond the preview
Go deeper on NCT05426824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05426824.